Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.

about

Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q46671185

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tocilizumab potentially preven ...... positive rheumatoid arthritis.

@en

Tocilizumab potentially preven ...... positive rheumatoid arthritis.

@nl

type

Item

label

Tocilizumab potentially preven ...... positive rheumatoid arthritis.

@en

Tocilizumab potentially preven ...... positive rheumatoid arthritis.

@nl

prefLabel

Tocilizumab potentially preven ...... positive rheumatoid arthritis.

@en

Tocilizumab potentially preven ...... positive rheumatoid arthritis.

@nl

P1476

Tocilizumab potentially preven ...... -positive rheumatoid arthritis

@en

P2093

Chia-Wei Hsieh

http://www.w3.org/2001/XMLSchema#string

Ching-Tsai Lin

http://www.w3.org/2001/XMLSchema#string

Hsin-Hua Chen

http://www.w3.org/2001/XMLSchema#string

Jun-Peng Chen

http://www.w3.org/2001/XMLSchema#string

Tsai-Ling Liao

http://www.w3.org/2001/XMLSchema#string

Tsu-Yi Hsieh

http://www.w3.org/2001/XMLSchema#string

Wei-Ting Hung

http://www.w3.org/2001/XMLSchema#string

Wen-Cheng Chao

http://www.w3.org/2001/XMLSchema#string

Wen-Nan Huang

http://www.w3.org/2001/XMLSchema#string

Yi-Hsing Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials

Evolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopenia

Biologic therapies and bone loss in rheumatoid arthritis.

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.

Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, rad

Evaluating osteoporotic fracture risk with the Fracture Risk Assessment Tool in Chinese patients with rheumatoid arthritis.

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

P304

e0188454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0188454

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Der-Yuan Chen

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29155868

http://www.w3.org/2001/XMLSchema#string

P932

5695761

http://www.w3.org/2001/XMLSchema#string